Direct hemoperfusion with polymyxin b-immobilized cartridge in severe sepsis due to intestinal perforation: Hemodynamic findings and clinical considerations in anticoagulation therapy;Hemoperfusión directa con el cartucho de polimixina b fijada en la sepsis grave secundaria a perforación intestinal: Hallazgos hemodinámicos y consideraciones clínicas con respecto a la anticoagulación

Revista Espanola de Quimioterapia

Volumn 26, Issue 2, 2013, Pages 151-158

  Maynar, Javier ^a   Martínez Sagasti, Fernando ^b   Herrera Gutiérrez, Manuel ^c   Martí, Francisco ^d   Candel, Francisco Javier ^b   Belda, Javier ^d   Castaño, Sergio ^a   Sanchez Izquierdo, José Ángel ^e  

^a Hospital Santiago   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN; POLYMYXIN B;

ADJUVANT THERAPY; AGED; ANTICOAGULANT THERAPY; ARTICLE; CENTRAL VENOUS PRESSURE; DRUG SAFETY; FEMALE; HEART INDEX; HEART STROKE VOLUME; HEMODYNAMICS; HEMOPERFUSION; HUMAN; INTESTINE PERFORATION; MALE; MULTICENTER STUDY; SEPSIS; SURVIVAL RATE; THROMBOCYTE COUNT;

ACID-BASE EQUILIBRIUM; AGED; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; BLOOD COAGULATION; CARDIAC OUTPUT; CENTRAL VENOUS PRESSURE; COHORT STUDIES; FEMALE; HEMODYNAMICS; HEMOPERFUSION; HUMANS; INTENSIVE CARE UNITS; INTESTINAL PERFORATION; LENGTH OF STAY; MALE; PATIENT SELECTION; POLYMYXIN B; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; STROKE VOLUME; VASOCONSTRICTOR AGENTS;

EID: 84890410221     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rangel-Frausto MS. Sepsis: still going strong. Arch Med Res 2005; 36:672-81.
2. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004; 190:527-34.
3. Candel FJ, Martinez-Sagasti F, Borges M, Maseda E, Herrera-Gutierrez M, Garnacho-Montero J, et al. Endotoxin adsortion as adjuvant therapy in gram negative severe sepsis. Rev Esp Quimioter 2010; 23:115-21.
4. Shimizu T, Hanasawa K, Sato K, Umeki M, Koga N, Naganuma T, et al. Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation. Langenbecks Arch Surg 2009; 394:303-11.
5. Tani T, Hanasawa K, Kodama M, Imaizumi H, Yonekawa M, Saito M, et al. Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 2001; 25:660-8.
6. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005; 23:400-5.
7. Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y, et al. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis 2002; 39:937-47.
8. Kushi H, Miki T, Okamaoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 2005; 9:R653-61.
9. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007; 11:R47.
10. Nakamura T, Ushiyama C, Suzuki Y, Inoue T, Shoji H, Shimada N, et al. Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillinresistant Staphylococcus aureus. J Hosp Infect 2003; 53:58-63.
11. Kawamata T, Imaizumi H, Yoshida M, Kaneko M. Polymyxin B-immobilized fiber improves hyperdynamic state in MRSA septic patients. Intensive Care Med 1997; 23:130-1.
12. Murakami M, Miyauchi Y, Nishida M, Okada H, Hamano K. Direct hemoperfusion using polymyxin-B immobilized fiber for septic shock after cardiac surgery. Circ J 2009; 73:658-61.
13. Antonelli M, Fumagalli R, Cruz DN, Brienza N, Giunta F. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial. Contrib Nephrol 2010; 167:83-90.
14. Zagli G, Bonizzoli M, Spina R, Cianchi G, Pasquini A, Anichini V, et al. Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis. Minerva Anestesiol 2010; 76:405-12.
15. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009; 301:2445-52.
16. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-6.
17. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30:536-55.
18. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
19. Navarro R, Guerrero M, Gonzalez M, Quecedo L, Garcia A, Ramasco F. Description of the hemodynamic and respiratory effects of hemoperfusion treatment with polymyxin B in patients with abdominal septic shock. Rev Esp Anestesiol Reanim 2012 Dec 28.
20. Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, et al. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial 2006; 10:12-8.
21. Smith I, Kumar P, Molloy S, Rhodes A, Newman PJ, Grounds RM, et al. Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med 2001; 27:74-83.
22. Stamm C, Cowan DB, Friehs I, Noria S, del Nido PJ, McGowan FX, Jr. Rapid endotoxin-induced alterations in myocardial calcium handling: obligatory role of cardiac TNF-alpha. Anesthesiology 200; 95:1396-405.
23. Wang Y, Liu Y, Sarker KP, Nakashima M, Serizawa T, Kishida A, et al. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 2000 Mar 24; 470:151-5.